UFP Technologies to Present at Raymond James Conference

The medical device manufacturer will host investor meetings at the annual event.

Published on Feb. 27, 2026

Got story updates? Submit your updates here. ›

UFP Technologies, Inc., a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, announced that Chairman and CEO R. Jeffrey Bailly and CFO Ron Lataille will participate in the upcoming Raymond James 47th Annual Institutional Investors Conference in Orlando, Florida from March 1-4, 2026. UFP's presentation is scheduled for 2:50 PM on Tuesday, March 3rd, and a live webcast will be available.

Why it matters

As a vital link in the medical device supply chain, UFP Technologies' participation in high-profile investor conferences like this one allows the company to showcase its capabilities, connect with potential customers and partners, and raise its profile among the investment community.

The details

UFP Technologies is a contract development and manufacturing organization that specializes in producing single-use and single-patient medical devices and components used in a wide range of medical applications. The company's presentation and one-on-one investor meetings at the Raymond James conference will provide an opportunity to highlight its expertise and growth strategy to the institutional investor audience.

  • The Raymond James 47th Annual Institutional Investors Conference will be held from March 1-4, 2026 in Orlando, Florida.
  • UFP Technologies' presentation is scheduled for 2:50 PM on Tuesday, March 3, 2026.

The players

R. Jeffrey Bailly

Chairman and Chief Executive Officer of UFP Technologies, Inc.

Ron Lataille

Chief Financial Officer of UFP Technologies, Inc.

UFP Technologies, Inc.

A contract development and manufacturing organization that specializes in single-use and single-patient medical devices.

Got photos? Submit your photos here. ›

The takeaway

UFP Technologies' participation in the high-profile Raymond James investor conference underscores the company's position as a leading contract manufacturer in the medical device industry and its commitment to engaging with the investment community.